Hadassah

Drug May Prevent Recurrence of Aggressive Cancer

Tuesday, Jun 20 2017

New Study led by Hadassah Hospital Oncologist Dr. Amir Sonnenblick

An international team led by Hadassah Hospital Oncologist Dr. Amir Sonnenblick reveals that giving a drug called metformin to diabetic women with a particularly aggressive form of breast cancer may prevent its recurrence.

This HER2-positive breast cancer tends to grow faster, is more likely to spread, and is more likely to come back, as compared with HER2-negative breast cancers. When insulin is given to HER2-positive patients, the treatment doubles their risk of cancer recurrence.

Previous studies have suggested that administering metformin, an anti-diabetic drug that primarily suppresses glucose production by the liver, may prevent or delay recurrence of breast cancer. Dr. Sonnenblick’s study, which was based on a very large database from a Phase III clinical trial, involved over 8,381 breast cancer patients from around the world. While 7,935 of the patients (94.7 percent) had no history of diabetes at diagnosis of their breast cancer, 186 (2.2 percent) had diabetes and were not being treated with metformin and 260 (3.1 percent) were diabetic and had been treated with metformin.

The researchers found that metformin may improve the worse prognosis that is associated with diabetes, mainly in patients with primary HER2-positive and hormone receptor–positive breast cancer.

 

“We believe that for patients with diabetes and HER2-positive and hormone receptor positive disease,” explains Dr. Sonnenblick, “it is reasonable to recommend metformin treatment if patients have not already received treatment and to avoid insulin use as much as possible. From a prognostic point of view, patients with diabetes and HER2-positive as well as hormone receptor–positive disease who are treated with insulin should be considered at higher risk for recurrence."

The study findings are highlighted in the May 2017 issue of the Journal of Clinical Oncology. The international team of researchers included physicians from Belgium, Brazil, Chile, Denmark, Ireland, Israel, Italy, Japan, Slovenia, Switzerland, the Netherlands, the United Kingdom, and the United States.

From 2013 to 2015, lead investigator Sonnenblick did a translational and clinical research fellowship in breast cancer at the Jules Bordet Institute in Brussels, Belgium.

Learn more about groundbreaking research at the Hadassah Medical Organization.

Related Stories

alt_text

Wednesday, Dec 2 2020

Hadassah Opens Follow-Up Clinic for Recovered COVID-19 Patients

In response to the large number of COVID-19 patients suffering from lingering health issues long after they recover from the virus, Hadassah Hospital Ein Kerem has opened a multidisciplinary clinic at its Pulmonary Institute to monitor and assess their physical and psychological symptoms.

READ MORE ›
alt_text

Tuesday, Dec 1 2020

One in 200,000: Identical Triplets Born at Hadassah Hospital Mount Scopus

Last year, Tamar gave birth to a stillborn baby. When she became pregnant again, she initially didn’t rush to have an ultrasound because of the pandemic. But she wanted to make sure there was a heartbeat, and so she went to Hadassah Hospital Mount Scopus for that ultrasound. There were three heartbeats—belonging to three identical babies!

READ MORE ›
alt_text

Tuesday, Dec 1 2020

Hadassah Completes Phase I Trial With Israeli-Made COVID-19 Vaccine

Phase I of the first clinical trial with Brilife, the COVID-19 vaccine developed by the Israel Institute for Biological Research, was completed at Hadassah Hospital Ein Kerem on November 26, when the 40th participant received the final dose.

READ MORE ›
alt_text

Tuesday, Nov 24 2020

[Hadassah On Call Podcast] COVID's Long-Term Health Impact, an Insider's Perspective

It's no longer enough to find a COVID-19 cure. Each day, we're discovering long-term complications for those who have recovered from the virus.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

More ›

Show More